4D PHARMA PLC has a total of 134 patent applications. It decreased the IP activity by 72.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, Australia and United Kingdom. Its main competitors in its focus markets pharmaceuticals, foods and drinks and environmental technology are NOVMETAPHARMA CO LTD, BIONAP S R L and WURTMAN RICHARD J.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Australia | 10 | |
#3 | United Kingdom | 10 | |
#4 | EPO (European Patent Office) | 9 | |
#5 | Israel | 9 | |
#6 | Singapore | 9 | |
#7 | China | 6 | |
#8 | Canada | 5 | |
#9 | Republic of Korea | 5 | |
#10 | Taiwan | 5 | |
#11 | WIPO (World Intellectual Property Organization) | 5 | |
#12 | Argentina | 4 | |
#13 | Brazil | 4 | |
#14 | Colombia | 4 | |
#15 | Hong Kong | 4 | |
#16 | Hungary | 4 | |
#17 | Japan | 4 | |
#18 | Morocco | 4 | |
#19 | Montenegro | 4 | |
#20 | Mexico | 4 | |
#21 | Serbia | 4 | |
#22 | EAPO (Eurasian Patent Organization) | 3 | |
#23 | New Zealand | 2 | |
#24 | Peru | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Environmental technology | |
#4 | Computer technology | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Foods | |
#4 | Special foods | |
#5 | Climate change adaptation technologies | |
#6 | Computational chemistry | |
#7 | Diagnosis and surgery | |
#8 | Healthcare informatics | |
#9 | Specific computer systems | |
#10 | Fodder |
# | Name | Total Patents |
---|---|---|
#1 | Crouzet Laureen | 70 |
#2 | Bernalier-Donadille Annick | 67 |
#3 | Habouzit Chloe | 67 |
#4 | Shanahan Fergus | 31 |
#5 | Jeffery Ian | 24 |
#6 | Stevenson Alex | 23 |
#7 | Mulder Imke | 23 |
#8 | Savignac Helene | 23 |
#9 | O'Toole Paul | 21 |
#10 | Laureen Crouzet | 9 |
Publication | Filing date | Title |
---|---|---|
GB202002902D0 | Compositions comprising bacterial strains | |
EP3803901A1 | Method for stratifying ibs patients | |
TW201821093A | Compositions comprising bacterial strains | |
GB201703548D0 | Compositions comprising bacterial strains | |
WO2017148596A1 | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity | |
GB201703552D0 | Compositions comprising bacterial strains | |
GB201621123D0 | Compositions comprising bacterial strains | |
GB201616016D0 | Compositions comprising bacterial strains | |
GB201612190D0 | Compositions comprising bacterial strains | |
GB201612191D0 | Compositions comprising bacterial strains | |
GB201603817D0 | Compositions comprising bacterial strains |